{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:04:06Z","timestamp":1789790646669,"version":"4.0.1"},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,9,15]]},"DOI":"10.2169\/internalmedicine.6404-25","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T22:10:55Z","timestamp":1770675055000},"page":"2477-2482","source":"Crossref","is-referenced-by-count":1,"title":["Levofloxacin-Induced Eosinophilic Pneumonia with Systemic Manifestations: A Case Report and Literature Review"],"prefix":"10.2169","volume":"65","author":[{"given":"Keigo","family":"Tokunaga","sequence":"first","affiliation":[{"name":"Department of Nephrology, Gyotoku General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Murasawa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Gyotoku General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisato","family":"Yamamura","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Gyotoku General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Aoyama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Gyotoku General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Camus P, Foucher P, Bonniaud PH, Ask K. Drug-induced infiltrative lung disease. Eur Respir J Suppl 32: 93s-100s, 2001.","DOI":"10.1183\/09031936.01.18s320093"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Skeoch S, Weatherley N, Swift AJ, et al. Drug-induced interstitial lung disease: a systematic review. J Clin Med 7: 356, 2018.","DOI":"10.3390\/jcm7100356"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Matsuno O. Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches. Respir Res 13: 39, 2012.","DOI":"10.1186\/1465-9921-13-39"},{"key":"4","unstructured":"4. Fujimori K. Levofloxacin-induced eosinophilic pneumonia complicated by bronchial asthma. Nihon Kokyuki Gakkai Zasshi (J Jpn Respir Soc) 38: 385-390, 2000 (in Japanese)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Castaneda C, Feng C, Feldberg A, Lee C, Abe O. Levofloxacin-induced acute eosinophilic pneumonitis: a case report and review. Chest 152 (4 Suppl): A256, 2017.","DOI":"10.1016\/j.chest.2017.08.282"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Jammalamadaka D, Zang H, Sandur S, et al. Pulmonary toxicity with fluoroquinolones. Internet J Pulm Med 11: 9886, 2008.","DOI":"10.5580\/1acc"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Camus P, Fanton A, Bonniaud P, Camus C, Foucher P. Interstitial lung disease induced by drugs and radiation. Respiration 71: 301-326, 2004.","DOI":"10.1159\/000079633"},{"key":"8","unstructured":"8. Japanese Respiratory Society. Guidelines for the Management of Drug-induced Lung Disease, 3rd ed. Japanese Respiratory Society, Tokyo, 2021 (in Japanese)."},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Stirton H, Shear NH, Dodiuk-Gad RP. Drug reaction with eosinophilia and systemic symptoms (DReSS)\/drug-induced hypersensitivity syndrome (DiHS) - Readdressing the DReSS. Biomedicines 10: 999, 2022.","DOI":"10.3390\/biomedicines10050999"},{"key":"10","unstructured":"10. Japanese Dermatological Association. Clinical Practice Guideline for Drug-Induced Hypersensitivity Syndrome (DIHS) 2023. Nihon Hifuka Gakkai Zasshi (Jpn J Dermatol) 134: 559-580, 2024 (in Japanese)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 169: 1071-1080, 2013.","DOI":"10.1111\/bjd.12501"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Katz U, Shoenfeld Y. Pulmonary eosinophilia. Clin Rev Allergy Immunol 34: 367-371, 2008.","DOI":"10.1007\/s12016-007-8053-y"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med 150: 1423-1438, 1994.","DOI":"10.1164\/ajrccm.150.5.7952571"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Matsuno O, Okubo T, Hiroshige S, et al. Drug-induced lymphocyte stimulation test is not useful for the diagnosis of drug-induced pneumonia. Tohoku J Exp Med 212: 49-53, 2007.","DOI":"10.1620\/tjem.212.49"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Akira M, Ishikawa H, Yamamoto S. Drug-induced pneumonitis: thin-section CT findings in 60 patients. Radiology 224: 852-860, 2002.","DOI":"10.1148\/radiol.2243011236"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Costabel U, Guzman J. Bronchoalveolar lavage in drug-induced lung disease. Clin Chest Med 25: 25-35, 2004.","DOI":"10.1016\/S0272-5231(03)00143-6"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Meyer KC. Diagnosis and management of interstitial lung disease. Transl Respir Med 2: 4, 2014.","DOI":"10.1186\/2213-0802-2-4"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/18\/65_6404-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:31:40Z","timestamp":1789788700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/18\/65_6404-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":17,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6404-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"6404-25"}}